Obstetric-Fetal Pharmacology Research Centers

Oseltamivir for influenza in pregnancy.

Beigi, R. H., Venkataramanan, R., & Caritis, S. N. (2014). Oseltamivir for influenza in pregnancy. Seminars in Perinatology, 38(8), 503-507. doi: 10.1053/j.semperi.2014.08.015. (PMID: 25281358)

Seminars in Perinatology

Seminars in Perinatology, 210(2):128.e1-6. doi: 10.1016/j.ajog.2013.10.008.

Challenges of studying drugs in pregnancy for off-label indications: Pravastatin for preeclampsia prevention.

Cleary, K. L., Roney, K., & Costantine, M. (2014). Challenges of studying drugs in pregnancy for off-label indications: Pravastatin for preeclampsia prevention. Seminars in Perinatology, 38(8), 523-527. doi: 10.1053/j.semperi.2014.08.019. (PMID: 25315293)

Pharmacological management of hypertension in pregnancy.

Easterling, T. R. (2014). Pharmacological management of hypertension in pregnancy. Seminars in Perinatology, 38(8), 487-495. doi: 10.1053/j.semperi.2014.08.016. (PMID: 25311173)

Antenatal corticosteroid therapy: Current strategies and identifying mediators and markers for response.

Falah, N., & Haas, D. M. (2014). Antenatal corticosteroid therapy: Current strategies and identifying mediators and markers for response. Seminars in Perinatology, 38(8), 528-533. doi: 10.1053/j.semperi.2014.08.018. (PMID: 25256192)

Prevention of preterm delivery with 17-hydroxyprogesterone caproate: Pharmacologic considerations.

Feghali, M., Venkataramanan, R., & Caritis, S. (2014). Prevention of preterm delivery with 17-hydroxyprogesterone caproate: Pharmacologic considerations. Seminars in Perinatology, 38(8), 516-522. doi: 10.1053/j.semperi.2014.08.013. (PMID: 25256193)

Studying the antiemetic effect of vitamin B6 for morning sickness: pyridoxine and pyridoxal are prodrugs.

Matok, I., Clark, S., Caritis, S., Miodovnik, M., Umans, J. G., Hankins, G., Mattison, D. R., & Koren, G. (2014). Studying the antiemetic effect of vitamin B6 for morning sickness: pyridoxine and pyridoxal are prodrugs. Journal of Clinical Pharmacology, 54(12), 1429-1433. doi: 10.1002/jcph.369. (PMID: 25052410)

Is personalized medicine achievable in obstetrics?

Quinney, S. K., Patil, A. S., & Flockhart, D. A. (2014). Is personalized medicine achievable in obstetrics?. Seminars in Perinatology, 38(8), 534-540. doi: 10.1053/j.semperi.2014.08.017. (PMID: 25282474)

Introduction. Common drugs in pregnancy: an update from the Obstetric-Fetal Pharmacology Research Unit Network.

Ren, Z., & Haneline, L. S. (2014). Introduction. Common drugs in pregnancy: an update from the Obstetric-Fetal Pharmacology Research Unit Network. Seminars in Perinatology, 38(8), 473-474. doi: 10.1053/j.semperi.2014.08.010. (PMID: 25267278)

Gestational diabetes mellitus management with oral hypoglycemic agents.

Ryu, R. J., Hays, K. E., & Hebert, M. F. (2014). Gestational diabetes mellitus management with oral hypoglycemic agents. Seminars in Perinatology, 38(8), 508-515. doi: 10.1053/j.semperi.2014.08.012. (PMID: 25315294)

Identification of CYP3A7 for glyburide metabolism in human fetal livers.

Shuster, D. L., Risler, L. J., Prasad, B., Calamia, J. C., Voellinger, J. L., Kelly, E. J., Unadkat, J. D., Hebert, M. F., Shen, D. D., Thummel, K. E., Mao, Q. (2014). Identification of CYP3A7 for glyburide metabolism in human fetal livers. Biochemical Pharmacology, 92(4), 690-700. doi: 10.1016/j.bcp.2014.09.025. (PMID: 25450675)

Basic obstetric pharmacology.

Zhao, Y., Hebert, M. F., & Venkataramanan, R. (2014). Basic obstetric pharmacology. Seminars in Perinatology, 38(8), 475-486. doi: 10.1053/j.semperi.2014.08.011. (PMID: 25281357)

Taste of a pill: Organic cation transporter-3 (OCT3) mediates metformin accumulation and secretion in salivary glands.

Lee, N., Duan, H., Hebert, M. F., Liang, C. J., Rice, K. M., & Wang, J. (2014). Taste of a pill: Organic cation transporter-3 (OCT3) mediates metformin accumulation and secretion in salivary glands. Journal of Biology and Chemistry, 289(39), 27055-27064. doi: 10.1074/jbc.M114.570564. (PMID: 25107910)

Pharmacoepidemiologic and in vitro evaluation of potential drug-drug interactions of sulfonylureas with fibrates and statins.

Schelleman, H., Han, X., Brensinger, C. M., Quinney, S. K., Bilker, W. B., Flockhart, D. A., Li, L., & Hennessy, S. (2014). Pharmacoepidemiologic and in vitro evaluation of potential drug-drug interactions of sulfonylureas with fibrates and statins. British Journal of Clinical Pharmacology, 78(3), 639-648. doi: 10.1111/bcp.12353. (PMID: 24548191)

Quantitative determination of telavancin in pregnant baboon plasma by solid-phase extraction and LC-ESI-MS.

Wang, X., Paul, J. A., Nanovskaya, T. N., Hankins, G. D., & Ahmed, M. S. (2014). Quantitative determination of telavancin in pregnant baboon plasma by solid-phase extraction and LC-ESI-MS. Pharmaceutical and Biomedical Analysis, 98, 107-112. doi: 10.1016/j.jpba.2014.04.030. (PMID: 24905291)

Maternal-fetal disposition of glyburide in pregnant mice is dependent on gestational age.

Shuster, D. L., Risler, L. J., Liang, C. K., Rice, K. M., Shen, D. D., Hebert, M. F., Thummel, K. E., & Mao, Q. (2014). Maternal-fetal disposition of glyburide in pregnant mice is dependent on gestational age. Journal of Pharmacology and Experimental Therapeutics, 350(2), 425-434. doi: 10.1124/jpet.114.213470. (PMID: 24898265)

Stability of hydroxyprogesterone caproate alone and in a compounded pharmaceutical product.

Zhao, Y., Bettinger, J., Caritis, S., & Venkataramanan, R. (2014). Stability of hydroxyprogesterone caproate alone and in a compounded pharmaceutical product. American Journal of Health-System Pharmacy, 71(13), 1120-1127. doi: 10.2146/ajhp130466. (PMID: 24939502)

Pharmacokinetics of indomethacin in pregnancy.

Rytting, E., Nanovskaya, T. N., Wang, X., Vernikovskaya, D. I., Clark, S. M., Cochran, M., Abdel-Rahman, S. M., Venkataramanan, R., Caritis, S. N., Hankins, G. D., Ahmed, M. S. (2014). Pharmacokinetics of indomethacin in pregnancy. Clinical Pharmacokinetics, 53(6), 545-51. doi: 10.1007/s40262-014-0133-6. (PMID: 24493205)

Pharmacokinetics of doxorubicin in pregnant women.

Ryu, R. J., Eyal, S., Kaplan, H. G., Akbarzadeh, A., Hays, K., Puhl, K., Easterling, T. R., Berg, S. L., Scorsone, K. A., Feldman, E. M., Umans, J. G., Miodovnik, M., & Hebert, M. F. (2014). Pharmacokinetics of doxorubicin in pregnant women. Cancer Chemotherapy and Pharmacology, 73(4), 789-797. doi: 10.1007/s00280-014-2406-z. (PMID: 24531558)

Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth

Caritis, S. N., Venkataramanan, R., Thom, E., Harper, M., Klebanoff, M. A., Sorokin, Y., Thorp, J. M. Jr., Varner, M. W., Wapner, R. J., Iams, J. D., Carpenter, M. W., Grobman, W. A., Mercer, B. M., Sciscione, A., Rouse, D. J., Ramin, S., & Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network and Obstetric-Fetal Pharmacology Research Units Network. (2014). Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth. American Journal of Obstetrics and Gynecology, 210(2), 128.e1-6. doi: 10.1016/j.ajog.2013.10.008. (PMID: 24113254)

Gestational diabetes induces alterations in the function of neonatal endothelial colony-forming cells

Blue, E. K., DiGiuseppe, R., Derr-Yellin, E., Acosta, J. C., Pay, S. L., Hanenberg, H., Schellinger, M. M., Quinney, S. K., Mund, J. A., Case, J., & Haneline, L. S. (2014). Gestational diabetes induces alterations in the function of neonatal endothelial colony-forming cells. Pediatric Research, 210(1), 47.e1-7. doi: 10.1016/j.ajog.2013.09.039. (PMID: 24232636)

Quality assessment of compounded 17-hydroxyprogesterone caproate

Chang, J., Zhao, Y., Zhao, W., Venkataramanan, R., Caritis, S. N., & Obstetrical-Fetal Pharmacology Research Units Network (2014). Quality assessment of compounded 17-hydroxyprogesterone caproate. American Journal of Obstetrics and Gynecology, 75(2), 266-272. doi: 10.1016/j.ajog.2013.09.039. (PMID: 24200163)

Pharmacogenetics and individualizing drug treatment during pregnancy

Haas, D. M. (2014). Pharmacogenetics and individualizing drug treatment during pregnancy. Pharmacogenomics, 15(1), 69-78. doi: 10.2217/pgs.13.228. (PMID: 24329192)

Drugs during Pregnancy and Lactation: Treatment Options and Risk Assessment, 3rd edition, 2014, p 294-339

Wisner KL, Schaefer C.  Psychotropic Drugs.  In Schaefer C, Peters P, Miller RK, eds. Drugs during  Pregnancy and Lactation: Treatment Options and Risk Assessment, 3rd edition, 2014, p 294-339.